These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 14742216)

  • 1. Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae.
    Jorgensen JH; Crawford SA; McElmeel ML; Whitney CG
    Antimicrob Agents Chemother; 2004 Feb; 48(2):605-7. PubMed ID: 14742216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain: in vitro activities of telithromycin and cethromycin.
    Morosini MI; Cantón R; Loza E; del Campo R; Almaraz F; Baquero F
    J Antimicrob Chemother; 2003 Jul; 52(1):50-5. PubMed ID: 12805254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of telithromycin against 13,874 Streptococcus pneumoniae isolates collected between 1999 and 2003.
    Farrell DJ; Felmingham D
    Antimicrob Agents Chemother; 2004 May; 48(5):1882-4. PubMed ID: 15105150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotypic characterization of macrolide-resistant strains of Streptococcus pneumoniae isolated in Quebec, Canada, and in vitro activity of ABT-773 and telithromycin.
    Weiss K; Guilbault C; Cortes L; Restieri C; Low DE;
    J Antimicrob Chemother; 2002 Sep; 50(3):403-6. PubMed ID: 12205066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of the ermB gene among erythromycin-resistant streptococcus pneumoniae isolates in Germany during the winter of 2000-2001 and in vitro activity of telithromycin.
    Kresken M; Henrichfreise B; Bagel S; Brauers J; Wiedemann B
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3193-5. PubMed ID: 15273149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms.
    Morosini MI; Cantón R; Loza E; Negri MC; Galán JC; Almaraz F; Baquero F
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2427-31. PubMed ID: 11502509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children.
    Johnson CN; Benjamin WH; Gray BM; Crain MC; Edwards KM; Waites KB
    Int J Antimicrob Agents; 2001 Dec; 18(6):531-5. PubMed ID: 11738340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations.
    Farrell DJ; Morrissey I; Bakker S; Buckridge S; Felmingham D
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3169-71. PubMed ID: 15273142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae.
    Miyashita N; Fukano H; Yoshida K; Niki Y; Matsushima T
    J Antimicrob Chemother; 2003 Sep; 52(3):497-9. PubMed ID: 12917246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An examination of the differential sensitivity to ketolide antibiotics in ermB strains of Streptococcus pyogenes and Streptococcus pneumoniae.
    Champney WS; Mentens N; Zurawick K
    Curr Microbiol; 2004 Oct; 49(4):239-47. PubMed ID: 15386111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of the first telithromycin-resistant Streptococcus pneumoniae isolate in Germany.
    Reinert RR; van der Linden M; Al-Lahham A
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3520-2. PubMed ID: 16048973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of cethromycin (ABT-773), a new ketolide, against Streptococcus pneumoniae strains that are not susceptible to penicillin or macrolides.
    Mason EO; Lamberth LB; Wald ER; Bradley JS; Barson WJ; Kaplan SL
    Antimicrob Agents Chemother; 2003 Jan; 47(1):166-9. PubMed ID: 12499186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.
    Zhanel GG; Palatnick L; Nichol KA; Bellyou T; Low DE; Hoban DJ
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1867-74. PubMed ID: 12760860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of telithromycin against penicillin-resistant Streptococcus pneumoniae isolates recovered from French children with invasive and noninvasive infections.
    Bingen E; Doit C; Loukil C; Brahimi N; Bidet P; Deforche D; Geslin P
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2345-7. PubMed ID: 12821495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides.
    Hoban DJ; Wierzbowski AK; Nichol K; Zhanel GG
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2147-50. PubMed ID: 11408241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F; Carnegy F; Willcock J; Amyes S
    J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
    Mazzariol A; Koncan R; Bahar G; Cornaglia G
    J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin.
    Felmingham D; Reinert RR; Hirakata Y; Rodloff A
    J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():25-37. PubMed ID: 12239226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologies.
    Davies TA; Kelly LM; Jacobs MR; Appelbaum PC
    J Clin Microbiol; 2000 Apr; 38(4):1444-8. PubMed ID: 10747123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.